Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma.
Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma.
复制标题
WGP 上调树突状细胞上的 GITRL 可改善小鼠 Lewis 肺癌的抗肿瘤免疫
DOI:
10.1371/journal.pone.0046936
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Wang S
中科院分区:
文献类型:
--
作者:
Tian J;Ma J;Ma K;Ma B;Tang X;Baidoo SE;Tong J;Yan J;Lu L;Xu H;Wang S
β-Glucans have been shown to function as a potent immunomodulator to stimulate innate and adaptive immune responses, which contributes to their anti-tumor property. However, their mechanisms of action are still elusive. Glucocorticoid-induced TNF receptor ligand (GITRL), a member of the TNF superfamily, binds to its receptor, GITR, on both effector and regulatory T cells, generates a positive co-stimulatory signal implicated in a wide range of T cell functions, which is important for the development of immune responses. In this study, we found that whole β-glucan particles (WGPs) could activate dendritic cells (DCs) via dectin-1 receptor, and increase the expression of GITRL on DCs in vitro and in vivo. Furthermore, we demonstrated that the increased GITRL on DCs could impair the regulartory T cell (Treg)-mediated suppression and enhance effector T cell proliferation in a GITR/GITRL dependent way. In tumor models, DCs with high levels of GITRL were of great potential to prime cytotoxic T lymphocyte (CTL) responses and down-regulate the suppressive activity of Treg cells, thereby leading to the delayed tumor progression. These findings suggest that particulate β-glucans can be used as an immunomodulator to stimulate potent T cell-mediated adaptive immunity while down-regulate suppressive immune activity via GITR/GITRL interaction, leading to a more efficient defense mechanism against tumor development.
登录
查看更多内容
DOI:
10.1038/nri2569
发表时间:
2009-07
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
Geijtenbeek TB;Gringhuis SI
通讯作者:
Gringhuis SI
DOI:
10.1084/jem.20021890
发表时间:
2003-05-05
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Brown GD;Herre J;Williams DL;Willment JA;Marshall AS;Gordon S
通讯作者:
Gordon S
影响因子:
8.7
作者:
Goodridge HS;Wolf AJ;Underhill DM
通讯作者:
Underhill DM
影响因子:
11.2
作者:
Bohn, JA;BeMiller, JN
通讯作者:
BeMiller, JN
影响因子:
15.9
作者:
Dillon, S;Agrawal, S;Pulendran, B
通讯作者:
Pulendran, B